Skip to content

← All stories

Markets

H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval

1 source ·2 articles ·1h ago

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·1h ago

H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval

Investing.com News ·1h ago

H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval